SCI Abstract

search
The optimization of outpatient hemodialysis management for AKI-D patients: A quality improvement study
The optimization of outpatient hemodialysis management for AKI-D patients: A quality improvement study
Introduction: In 2017, the Centers for Medicare and Medicaid Services allowed survivors of hospitalized acute kidney injur...
Work Experiences of the Interdisciplinary Dialysis Workforce in the United States: A Cross-Sectional Survey
Work Experiences of the Interdisciplinary Dialysis Workforce in the United States: A Cross-Sectional Survey
Introduction: Suboptimal dialysis care may be in part due to staff issues such as job dissatisfaction, burnout, work overl...
Acute kidney injury in coronavirus disease and association with thrombosis
Acute kidney injury in coronavirus disease and association with thrombosis
Introduction: Coronavirus disease (COVID-19) is a global pandemic which continues to cause systemic inflammation leading t...
Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients
Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients
Introduction: Although high dose erythropoiesis-stimulating agent (ESA) has been shown to increase mortality risk and adve...
IgA Nephropathy with Crescents: A Single-Center Experience
IgA Nephropathy with Crescents: A Single-Center Experience
<b><i>Introduction:</i></b> The presence of crescents in IgA nephropathy (IgAN) has been associate...
Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide
Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide
Introduction: In the AWARD-7 study in patients with type 2 diabetes and moderate-to-severe chronic kidney disease, once-we...
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis popul...
Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists
Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists
Background: Diabetic kidney disease (DKD) is a common disorder with multiple serious clinical implications, including an i...
Biomarkers of covert acid stress in patients with CKD: A cross-sectional study
Biomarkers of covert acid stress in patients with CKD: A cross-sectional study
Introduction: Like metabolic acidosis, earlier stages of acid (H+) stress, including an ongoing H+ challenge in the form ...